Please login to the form below

Not currently logged in
Email:
Password:

NovoMix 30

This page shows the latest NovoMix 30 news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk recalls insulin

Novo Nordisk recalls insulin

Novo Nordisk recalls insulin. Batches of prefilled NovoMix 30 pens found to have incorrect amount of diabetes treatment. ... Diabetes patients in Europe were warned to be on alert after Novo Nordisk announced a recall of several batches of its NovoMix

Latest news

  • The impact of insulin

    The company has modified the product into the more user-friendly formulations: NovoMix 30 is a dual-release insulin analog formulation of one rapid- and one intermediate-acting form of insulin ... aspart delivered in a single injection, and NovoMix 50

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics